Myriocin from Mycelia sterilia is primarily used in research and pharmaceutical applications due to its potent immunosuppressive properties. It is known to inhibit serine palmitoyltransferase, a key enzyme in the sphingolipid biosynthesis pathway, making it valuable in studies related to autoimmune diseases and inflammation. Additionally, it has shown potential in cancer research by inducing apoptosis in certain cancer cells. Myriocin is also explored for its neuroprotective effects, particularly in conditions like multiple sclerosis, where it helps reduce demyelination. Its ability to modulate lipid metabolism further extends its application in metabolic disorder studies.